Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: A possible role in the resistance to HIV of HIV-exposed seronegative individuals

Mara Biasin; Luca Piacentini; Sergio Lo Caputo; Yasuyoshi Kanari; Giuliana Magri; Daria Trabattoni; Valentina Naddeo; Lucia Lopalco; Alberto Clivio; Eugenio Cesana; Francesca Fasano; Cristina Bergamaschi; Francesco Mazzotta; Masaaki Miyazawa; Mario Clerici

doi:10.1086/511988

Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: A possible role in the resistance to HIV of HIV-exposed seronegative individuals

Mara Biasin, Luca Piacentini, Sergio Lo Caputo, Yasuyoshi Kanari, Giuliana Magri, Daria Trabattoni, Valentina Naddeo, Lucia Lopalco, Alberto Clivio, Eugenio Cesana, Francesca Fasano, Cristina Bergamaschi, Francesco Mazzotta, Masaaki Miyazawa, Mario Clerici

Research output: Contribution to journal › Article › peer-review

Abstract

Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G (APOBEC3G), a human cytidine deaminase, is a potent inhibitor of HIV replication. To explore a possible role of this protein in modulating in vivo susceptibility to HIV infection, we analyzed APOBEC3G expression in HIV-exposed seronegative individuals, HIV-seropositive patients, and healthy control subjects. The results showed that the expression of APOBEC3G is significantly increased in peripheral blood mononuclear cells (PBMCs) - mainly CD14 ⁺ cells - and in cervical tissues of HIV-exposed seronegative individuals. Higher APOBEC3G expression correlated with a reduced susceptibility of PBMCs to in vitro infection with the HIV-1_Ba-L R5 strain. APOBEC3G could be important in modulating in vivo susceptibility to sexually transmitted HIV infection.

Original language	English
Pages (from-to)	960-964
Number of pages	5
Journal	Journal of Infectious Diseases
Volume	195
Issue number	7
DOIs	https://doi.org/10.1086/511988
Publication status	Published - Apr 1 2007

ASJC Scopus subject areas

Public Health, Environmental and Occupational Health
Immunology

Access to Document

10.1086/511988

Cite this

Biasin, M., Piacentini, L., Lo Caputo, S., Kanari, Y., Magri, G., Trabattoni, D., Naddeo, V., Lopalco, L., Clivio, A., Cesana, E., Fasano, F., Bergamaschi, C., Mazzotta, F., Miyazawa, M., & Clerici, M. (2007). Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: A possible role in the resistance to HIV of HIV-exposed seronegative individuals. Journal of Infectious Diseases, 195(7), 960-964. https://doi.org/10.1086/511988

Biasin, M, Piacentini, L, Lo Caputo, S, Kanari, Y, Magri, G, Trabattoni, D, Naddeo, V, Lopalco, L, Clivio, A, Cesana, E, Fasano, F, Bergamaschi, C, Mazzotta, F, Miyazawa, M & Clerici, M 2007, 'Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: A possible role in the resistance to HIV of HIV-exposed seronegative individuals', Journal of Infectious Diseases, vol. 195, no. 7, pp. 960-964. https://doi.org/10.1086/511988

@article{2d402005937d41a193097afc723ec830,

title = "Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: A possible role in the resistance to HIV of HIV-exposed seronegative individuals",

abstract = "Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G (APOBEC3G), a human cytidine deaminase, is a potent inhibitor of HIV replication. To explore a possible role of this protein in modulating in vivo susceptibility to HIV infection, we analyzed APOBEC3G expression in HIV-exposed seronegative individuals, HIV-seropositive patients, and healthy control subjects. The results showed that the expression of APOBEC3G is significantly increased in peripheral blood mononuclear cells (PBMCs) - mainly CD14 + cells - and in cervical tissues of HIV-exposed seronegative individuals. Higher APOBEC3G expression correlated with a reduced susceptibility of PBMCs to in vitro infection with the HIV-1Ba-L R5 strain. APOBEC3G could be important in modulating in vivo susceptibility to sexually transmitted HIV infection.",

author = "Mara Biasin and Luca Piacentini and {Lo Caputo}, Sergio and Yasuyoshi Kanari and Giuliana Magri and Daria Trabattoni and Valentina Naddeo and Lucia Lopalco and Alberto Clivio and Eugenio Cesana and Francesca Fasano and Cristina Bergamaschi and Francesco Mazzotta and Masaaki Miyazawa and Mario Clerici",

year = "2007",

month = apr,

day = "1",

doi = "10.1086/511988",

language = "English",

volume = "195",

pages = "960--964",

journal = "Journal of Infectious Diseases",

issn = "0022-1899",

publisher = "Oxford University Press",

number = "7",

}

TY - JOUR

T1 - Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G

T2 - A possible role in the resistance to HIV of HIV-exposed seronegative individuals

AU - Biasin, Mara

AU - Piacentini, Luca

AU - Lo Caputo, Sergio

AU - Kanari, Yasuyoshi

AU - Magri, Giuliana

AU - Trabattoni, Daria

AU - Naddeo, Valentina

AU - Lopalco, Lucia

AU - Clivio, Alberto

AU - Cesana, Eugenio

AU - Fasano, Francesca

AU - Bergamaschi, Cristina

AU - Mazzotta, Francesco

AU - Miyazawa, Masaaki

AU - Clerici, Mario

PY - 2007/4/1

Y1 - 2007/4/1

N2 - Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G (APOBEC3G), a human cytidine deaminase, is a potent inhibitor of HIV replication. To explore a possible role of this protein in modulating in vivo susceptibility to HIV infection, we analyzed APOBEC3G expression in HIV-exposed seronegative individuals, HIV-seropositive patients, and healthy control subjects. The results showed that the expression of APOBEC3G is significantly increased in peripheral blood mononuclear cells (PBMCs) - mainly CD14 + cells - and in cervical tissues of HIV-exposed seronegative individuals. Higher APOBEC3G expression correlated with a reduced susceptibility of PBMCs to in vitro infection with the HIV-1Ba-L R5 strain. APOBEC3G could be important in modulating in vivo susceptibility to sexually transmitted HIV infection.

AB - Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G (APOBEC3G), a human cytidine deaminase, is a potent inhibitor of HIV replication. To explore a possible role of this protein in modulating in vivo susceptibility to HIV infection, we analyzed APOBEC3G expression in HIV-exposed seronegative individuals, HIV-seropositive patients, and healthy control subjects. The results showed that the expression of APOBEC3G is significantly increased in peripheral blood mononuclear cells (PBMCs) - mainly CD14 + cells - and in cervical tissues of HIV-exposed seronegative individuals. Higher APOBEC3G expression correlated with a reduced susceptibility of PBMCs to in vitro infection with the HIV-1Ba-L R5 strain. APOBEC3G could be important in modulating in vivo susceptibility to sexually transmitted HIV infection.

UR - http://www.scopus.com/inward/record.url?scp=33947416193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947416193&partnerID=8YFLogxK

U2 - 10.1086/511988

DO - 10.1086/511988

M3 - Article

C2 - 17330785

AN - SCOPUS:33947416193

VL - 195

SP - 960

EP - 964

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 7

ER -

Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: A possible role in the resistance to HIV of HIV-exposed seronegative individuals

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this